337 related articles for article (PubMed ID: 16344616)
1. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Wegener's granulomatosis].
Riccieri V; Valesini G
Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and management of small vessel vasculitides].
Pettersson T; Karjalainen A
Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
[TBL] [Abstract][Full Text] [Related]
5. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
6. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
[TBL] [Abstract][Full Text] [Related]
7. Maintaining remission in a patient with vasculitis.
Flossmann O; Jayne DR
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
[TBL] [Abstract][Full Text] [Related]
8. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
9. Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.
Huchzermeyer C; Mardin C; Holbach L; Zwerina J; Schett G; Rech J
Clin Rheumatol; 2013 Mar; 32 Suppl 1():S97-101. PubMed ID: 20862503
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
11. What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
de Groot K; Jayne D
Clin Nephrol; 2005 Dec; 64(6):480-4. PubMed ID: 16370164
[TBL] [Abstract][Full Text] [Related]
12. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
Monach PA
Presse Med; 2013 Apr; 42(4 Pt 2):575-6. PubMed ID: 23453209
[No Abstract] [Full Text] [Related]
13. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
Langford CA; Talar-Williams C; Barron KS; Sneller MC
Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide.
Steinman TI; Jaffe BF; Monaco AP; Wolff SM; Fauci AS
Am J Med; 1980 Mar; 68(3):458-60. PubMed ID: 6987874
[TBL] [Abstract][Full Text] [Related]
15. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
Santana AN; Woronik V; Halpern AS; Barbas CS
J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
[TBL] [Abstract][Full Text] [Related]
16. Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.
Flossmann O; Baslund B; Bruchfeld A; Tervaert JW; Hall C; Heinzel P; Hellmich B; Luqmani RA; Nemoto K; Tesar V; Jayne DR
Ann Rheum Dis; 2009 Jul; 68(7):1125-30. PubMed ID: 18713783
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
[TBL] [Abstract][Full Text] [Related]
18. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS;
Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558
[TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
[No Abstract] [Full Text] [Related]
20. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
